brain-cancer

Documents about brain-cancer

• Stereotactic Radiosurgery or Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases That Have Been Removed By Surgery#850229ClinicalTrials.gov
• Pilot Immunotherapy Trial for Recurrent Malignant Gliomas#154638ClinicalTrials.gov
• Chronic stress-induced brain-derived small extracellular vesicles promote colorectal cancer through Treg differentiation.#479182NCBI PubMed Central
• Phase II Study of SOM230 in Patients With Recurrent or Progressive Meningioma#860081ClinicalTrials.gov
• Prognostic Value of Neurometabolic Networks in CRC (PVNM-CRC)#897928ClinicalTrials.gov
• Temozolomide and SCH66336 for Recurrent Glioblastoma Multiforme#905894ClinicalTrials.gov
• Panobinostat and Stereotactic Radiation Therapy in Treating Patients With Brain Tumors#892575ClinicalTrials.gov
• Evaluation of the Efficacy and Safety of Furmonertinib Combined with Bevacizumab As First-Line Treatment for EGFR-Positive Non-Small Cell Lung Cancer with Brain Metastases: a Single-Arm, Open-Label, Prospective Phase II Clinical Study#889382ClinicalTrials.gov
• Breast Cancer & Antiestrogenic Therapy & Brain#844191ClinicalTrials.gov
• A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma#857296ClinicalTrials.gov
• Study on the Treatment of HER2-negative Breast Cancer Brain Metastases With Radiotherapy Combined With Anlotinib#848446ClinicalTrials.gov
• Cognitive Training in Attenuating Attention Deficits/Child Treatment for Cancer#893960ClinicalTrials.gov
• A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer With Asymptomatic Untreated Brain Metastasis#979710ClinicalTrials.gov
• Safety and Efficacy Real-world Data of Trastuzumab Deruxtecan and Sacituzumab Govitecan#1009170ClinicalTrials.gov
• Maternal occupational physical activity during pregnancy and childhood cancers in Denmark 1968–2013#612289eScholarship
• Nomogram integrating MRI radiomics and white matter hyperintensity grading for predicting overall survival in patients with non-small cell lung cancer and brain metastases receiving whole-brain radiotherapy.#402596NCBI PubMed Central
• Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer#807820ClinicalTrials.gov
• Acceptance and Commitment Therapy for Neuro-Oncology Wellbeing#812501ClinicalTrials.gov
• Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid Tumors#864617ClinicalTrials.gov
• Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma#869782ClinicalTrials.gov
• Neurocognitive Assessment CNSL and LGG#870978ClinicalTrials.gov
• Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma#905550ClinicalTrials.gov
• Phase Ⅲ Trial of WBRT Versus Erlotinib Concurrent Whole-brain Radiation Therapy as first-line Treatment for Patients With Multiple Brain Metastases From Non-small-cell Lung Cancer(ENTER): a Multicentre, Open-label, Randomised Study#979785ClinicalTrials.gov
• Dendritic Cell Cancer Vaccine for High-grade Glioma#878133ClinicalTrials.gov
• From tumor metabolism to brain circuits: METTL14 as a SAM sensor driving pain-depression in pancreatic cancer.#242193NCBI PubMed Central
• Interleukin-34-Induced Arg1+ Macrophages Play a Key Role in Breast Cancer Brain Metastasis.#275692NCBI PubMed Central
• The neuro-immune-vascular landscape of lung cancer brain metastasis: insights from organoid models.#636411NCBI PubMed Central
• A Pilot Study to Determine Nutrition Status in Glioblastoma Multiforme Patients#908423ClinicalTrials.gov
• Cognitive Training and Brain Stimulation in Women With Post-chemotherapy Cognitive Impairment#918395ClinicalTrials.gov
• Ringworm and Irradiation#343938DOAB PROD Instance
• 68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients#800619ClinicalTrials.gov
• Depocyt® With Sorafenib in Neoplastic Meningitis#860819ClinicalTrials.gov
• A Pilot RCT of the PRISM Intervention for AYAs With Cancer#993307ClinicalTrials.gov
• Motexafin Gadolinium in Treating Patients With Glioblastoma Multiforme Who Are Undergoing Radiation Therapy to the Brain#845464ClinicalTrials.gov
• Window of Opportunity Study of DSP-0390 in Gliomas#902245ClinicalTrials.gov
• 9-ING-41 in Pediatric Patients With Refractory Malignancies.#849154ClinicalTrials.gov
• Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research#979840ClinicalTrials.gov
• Advanced MRI Sequences for Radiation Therapy Treatment Planning#869935ClinicalTrials.gov
• Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom#1009530ClinicalTrials.gov
• Metformin in Children With Relapsed or Refractory Solid Tumors#184807ClinicalTrials.gov
• Intrathecal Pemetrexed for SCLC Patients With Refractory Brain Metastases or Leptomeninges Metastatic#811349ClinicalTrials.gov
• Delayed 18F-FDG PET/CT in Improving Visualization of Brain Tumors in Patients With Glioblastoma#833213ClinicalTrials.gov
• 18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology#912542ClinicalTrials.gov
• A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Solid Tumors and Metastases to Brain (TUCATEMEB)#832919ClinicalTrials.gov
• Fenretinide in Treating Patients With Recurrent Malignant Glioma#893037ClinicalTrials.gov
• Combination Chemotherapy Plus Radiation Therapy in Treating Adult Patients With Brain Cancer#901084ClinicalTrials.gov
• High Light and Low Light Dose PDT in Glioma#981495ClinicalTrials.gov
• ENDO-BRAIN: Effects of Endocrine Adjuvant Therapy with Aromatase Inhibitors on the Cognitive Function of Breast Cancer Patients#802559ClinicalTrials.gov
• A Phase II Study of SHR-A1811 Combined With Radiotherapy in HER2-positive and HER2-low Breast Cancer Brain Metastases#861377ClinicalTrials.gov
• Carmustine Followed By Surgery in Treating Patients With Recurrent Supratentorial Malignant Glioma or Metastatic Brain Neoplasm#850898ClinicalTrials.gov